A detailed history of Callan Family Office, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 36,720 shares of ELAN stock, worth $415,670. This represents 0.03% of its overall portfolio holdings.

Number of Shares
36,720
Holding current value
$415,670
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$11.63 - $14.67 $427,053 - $538,682
36,720 New
36,720 $445 Million
Q1 2023

May 12, 2023

BUY
$8.79 - $14.58 $101,084 - $167,670
11,500 New
11,500 $108 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.37B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.